Best ETFs to Invest In, According to AI Analyst, 4/22/2026

Exchange-traded funds (ETFs) help investors gain exposure to the desired sector/asset class and earn attractive returns while lowering overall risk through diversification. However, the vast universe of ETFs can make selection difficult for retail investors. TipRanks’ ETF AI Analyst helps pick attractive ETFs that can generate solid returns.

Claim 30% Off TipRanks

Here, we will look at three ETFs rated Outperform by the AI Analyst, with the potential to generate strong total returns (capital appreciation and dividends): Vanguard Value ETF (VTV), NEOS S&P 500 High Income ETF (SPYI), and Health Care Select Sector SPDR Fund (XLV).

Using TipRanks’ Stock Comparison Tool, let’s look at a few metrics of these ETFs.

1. Vanguard Value ETF (VTV) — The VTV tracks the CRSP US Large Cap Value Index and provides exposure to stocks that are undervalued relative to their fundamentals. It provides investors with the opportunity to capitalize on potential market inefficiencies. The ETF AI Analyst has a price target of $219 on the VTV ETF, implying about 8% upside potential. Additionally, the VTV ETF offers a dividend yield of 1.95%. The Outperform rating on VTV is based on companies like Johnson & Johnson (JNJ), Walmart (WMT), Exxon Mobil (XOM), and Micron Technology (MU).
2. NEOS S&P 500 High Income ETF (SPYI) — The SPYI ETF seeks to distribute high monthly income generated by gaining exposure to constituents of the S&P 500 Index (SPX) and pursuing a data-driven call option strategy. The ETF AI Analyst has a price target of $56 on the SPYI ETF, implying 7.65% upside potential. Plus, SPYI offers a high dividend yield of about 12%. The AI Analyst’s bullish stance on SPYI is based on tech giants like Apple (AAPL), Microsoft (MSFT), Nvidia (NVDA), and Alphabet (GOOGL).
3. Health Care Select Sector SPDR Fund (XLV) — The XLV ETF tracks the S&P Health Care Select Sector Index and offers exposure to companies in the pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. The ETF AI Analyst has a price target of $166 on the XLV ETF, indicating 13.3% upside potential. Plus, XLV offers a dividend yield of 1.71%. The Outperform rating on XLV is backed by healthcare giants such as Johnson & Johnson and Merck (MRK).